Abstract

Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic avenues include gene silencing and modulation of repeat instability. However, there are major mechanistic gaps in our understanding of these processes, which prevent the rational design of an efficient treatment. To address this, we developed a novel system, ParB/ANCHOR-mediated Inducible Targeting (PInT), in which any protein can be recruited at will to a GFP reporter containing an expanded CAG/CTG repeat. Previous studies have implicated the histone deacetylase HDAC5 and the DNA methyltransferase DNMT1 as modulators of repeat instability via mechanisms that are not fully understood. Using PInT, we found no evidence that HDAC5 or DNMT1 modulate repeat instability upon targeting to the expanded repeat, suggesting that their effect is independent of local chromatin structure. Unexpectedly, we found that expanded CAG/CTG repeats reduce the effectiveness of gene silencing mediated by targeting HDAC5 and DNMT1. The repeat-length effect in gene silencing by HDAC5 was abolished by a small molecule inhibitor of HDAC3. Our results have important implications on the design of epigenome editing approaches for expanded CAG/CTG repeat disorders. PInT is a versatile synthetic system to study the effect of any sequence of interest on epigenome editing.

Highlights

  • There are 14 neurological and neuromuscular phenotypes caused by the expansion of CAG/CTG repeat [1]

  • We developed a novel system, ParB/ANCHOR-mediated Inducible Targeting (PInT), in which any protein can be recruited at will to a GFP reporter containing an expanded CAG/CTG repeat

  • Using PInT, we found no evidence that histone deacetylase 5 (HDAC5) or DNA methyltransferase 1 (DNMT1) modulate repeat instability upon targeting to the expanded repeat, suggesting that their effect is independent of local chromatin structure

Read more

Summary

Introduction

There are 14 neurological and neuromuscular phenotypes caused by the expansion of CAG/CTG repeat [1]. The most common ones are myotonic dystrophy type 1 and Huntington’s disease. Their cellular phenotypes are caused by the expression of an expanded allele that generates toxic RNAs and/or peptides, which affect gene expression, splicing, and protein aggregation in trans [2,3]. These mechanisms are thought to be worsened by somatic expansion of the expanded allele, which occurs in afflicted individuals over their lifetime [4]. There is no cure for these diseases, but modulating somatic expansion or inducing contractions are being explored as therapeutic approaches [4]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call